These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36869794)

  • 1. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
    Wang AY; Lo WK; Cheung SC; Tang TK; Yau YY; Lang BH
    Nephrol Dial Transplant; 2023 Jul; 38(8):1823-1835. PubMed ID: 36869794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial.
    Wang AY; Tang TK; Yau YY; Lo WK
    Am J Kidney Dis; 2024 Apr; 83(4):456-466.e1. PubMed ID: 38040277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
    Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism.
    Eddington H; Chinnadurai R; Alderson H; Ibrahim ST; Chrysochou C; Green D; Erekosima I; Hutchison A; Bubtana A; Hegarty J; Kalra PA
    BMC Nephrol; 2021 Mar; 22(1):106. PubMed ID: 33757437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of cinacalcet withdrawal in Australian dialysis patients.
    Ruderman I; Holt SG; Kirkland GS; Maslen S; Hawley CM; Oliver V; Krishnasamy R; Gray NA; Talaulikar GS; Nelson CL; Rajaram Y; Gock H; Au E; Elder GJ; Mainra R; Toussaint ND
    Intern Med J; 2019 Jan; 49(1):48-54. PubMed ID: 29992701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
    Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
    Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
    Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
    Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
    Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroidectomy: still the best choice for the management of severe secondary hyperparathyroidism.
    Ramos LGF; Cortes DDPVR; Reis LMD; Montenegro FLM; Arap SS; Brescia MDG; Custódio MR; Jorgetti V; Elias RM; Moysés RMA
    J Bras Nefrol; 2024; 46(2):e20230024. PubMed ID: 38039492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2012 Jul; 22(7):1083-8. PubMed ID: 22750941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.
    Warady BA; Ng E; Bloss L; Mo M; Schaefer F; Bacchetta J
    Pediatr Nephrol; 2020 Sep; 35(9):1679-1697. PubMed ID: 32367309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
    Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis.
    Komaba H; Hamano T; Fujii N; Moriwaki K; Wada A; Masakane I; Nitta K; Fukagawa M
    J Clin Endocrinol Metab; 2022 Jun; 107(7):2016-2025. PubMed ID: 35277957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
    Cozzolino M; Ketteler M; Martin KJ; Sharma A; Goldsmith D; Khan S
    Nephrol Dial Transplant; 2014 Apr; 29(4):899-905. PubMed ID: 24500308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients.
    Li JG; Xiao ZS; Hu XJ; Li Y; Zhang X; Zhang SZ; Shan AQ
    Medicine (Baltimore); 2017 Dec; 96(49):e9050. PubMed ID: 29245308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism.
    Chow KM; Szeto CC; Kwan BC; Cheng PM; Pang WF; Leung CB; Li PK
    Nephrology (Carlton); 2014 Jun; 19(6):339-44. PubMed ID: 24589316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.